Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update-Reference-Cited by-同舟云学术

Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update

Published:2020-01 Issue:1 Volume:13 Page:25-31
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Jin Ting,Zhang Qun,Luo Dong-Hua,Jiang Feng,Jin Qi-Feng,Chen Yuan-Yuan,Chen Xiao-Zhong,Mao Wei-Min

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Cost-effectiveness of screening for nasopharyngeal carcinoma among Asian-American Men in the United States;Harris;Otolaryngol Head Neck Surg,2019

3. National Comprehensive Cancer Network. Head and Neck Cancers (Version 2.2019 – June 28, 2019). https://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf. Accessed July 5, 2019.

4. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis;Xu;Oral Oncol,2018

5. Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era;Guo;Jpn J Clin Oncol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis;Cancer Medicine;2022-09-17

2. The efficacy and safety of concurrent chemoradiotherapy with induction chemotherapy vs. concurrent chemoradiotherapy alone for locally advanced nasopharyngeal carcinoma: a systematic-review and meta-analysis;Translational Cancer Research;2022-05

3. Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study;Cancer Management and Research;2021-09

4. Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better With Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma;Cureus;2021-01-30

5. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma;Oral Oncology;2020-12